Establishment Labs Holdings (ESTA) Cash from Operations Growth (3y) (2020 - 2026)
Powered by 
Analysis
Establishment Labs Holdings (ESTA) Cash from Operations Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 27.41% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 16.81% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 27.02% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 22.38% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 30.85% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 168.71% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 16.21% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 12.26% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 9.30% |
| 10 | Establishment Labs Holdings | 2.25 Bn | 2.18 Bn | 47.71 Mn | 16.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.23% |
| Mar 31, 2026 | 40.65% |
| Dec 31, 2025 | 77.39% |
| Sep 30, 2025 | 20.01% |
| Jun 30, 2025 | -18.29% |
| Mar 31, 2025 | -62.39% |
| Dec 31, 2024 | -39.10% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -159.07% |
| Mar 31, 2024 | -19.38% |
| Dec 31, 2023 | -63.53% |
| Sep 30, 2023 | -117.87% |
| Jun 30, 2023 | -66.71% |
| Mar 31, 2023 | -44.71% |
| Dec 31, 2022 | -51.56% |
| Sep 30, 2022 | -26.35% |
| Jun 30, 2022 | -17.06% |
| Mar 31, 2022 | 15.42% |
| Dec 31, 2021 | 3.13% |
| Sep 30, 2021 | -5.87% |